News · Case Studies · Insights from Royal Brompton & Harefield

Total Page:16

File Type:pdf, Size:1020Kb

News · Case Studies · Insights from Royal Brompton & Harefield Case Notes News · Case Studies · Insights From Royal Brompton & Harefield Hospitals · London International Edition 2020 Welcome to the International Edition 2020 of Case Notes Contents At Royal Brompton & Harefield Hospitals Specialist Care, private patients can access the highest quality diagnostics, treatment and care for heart and lung conditions. We are based in three convenient London locations – Royal Brompton Hospital in Chelsea, Harefield Hospital in Middlesex and 77 Wimpole Street in the Harley Street Medical Area. I am delighted to share with you our latest news and a range of articles to A life-saving alternative showcase the knowledge and skills treatment for faulty heart valves of our incredible team of expert PAGE 6 consultants and specialists. David Shrimpton The RB&HH transcatheter valve Managing Director, service provides access to alternative RB&HH Specialist Care life-saving treatments for faulty heart valves. Find out about the TAVI procedure led by Dr Simon Davies, and the most experienced MitraClip Improved quality of life with MitraClip therapy therapy service in the UK led by Dr PAGE 8 Robert Smith. Furthermore, discover the latest treatment for calcified coronary What's new? arteries using intravascular lithotrispy. PAGE 2 Revolutionary technique If you have any questions about our avoids numerous surgeries services, or you would like to refer for heart patients a patient, please get in touch – we would be delighted to hear from you. World-class care across PAGE 14 three London locations PAGE 4 Minimally invasive single A game changer in improving port lung resection patient survival rates PAGE 18 PAGE 12 Contact us Revolutionary technology Social news feed Advanced treatment for [email protected] to treat calcification PAGE 20 severe heart failure www.rbhh-specialistcare.co.uk PAGE 10 PAGE 16 2 3 What’s new? Royal Brompton Hospital doctors treat record number Consultants awarded academic promotions of premature babies with pioneering catheter interventions by the National Heart and Lung Institute Doctors at Royal Brompton Hospital have treated Nine consultants at Royal Brompton & Harefield • Professor Konstantinos Dimopoulos, consultant cardiologist, more babies using cardiac catheter interventions NHS Foundation Trust have been recognised in the becomes professor of practice in adult congenital heart disease and pulmonary hypertension than any other centre in Europe. National Heart and Lung Institute recent academic • Professor Sabine Ernst, consultant cardiologist, is now More than 80 premature babies with patent ductus arteriosus promotions, which celebrate the work of academics professor of practice in cardiology (PDA) have been treated at the hospital using this pioneering in the field of medicine, engineering, natural catheter procedure, which takes just 20 minutes and prevents the sciences and business. • Professor Jennifer Keegan, principal physicist, becomes need for open heart surgery. professor of practice in cardiovascular magnetic resonance The consultants recognised in this year’s promotions are: The procedure involves inserting a small device made from wire • Professor Duncan Macrae, consultant in paediatric intensive • Dr Sonya Babu-Narayan, consultant cardiologist, has been mesh into the heart (through a catheter inserted via a vein in the care medicine, becomes professor of practice in paediatric promoted to reader in adult congenital heart disease baby’s leg) and blocks the opening in the heart to stop the leak. intensive care medicine It is guided into place using echocardiography imaging, which uses • Dr William Man, consultant chest physician, has been • Professor Sanjay Prasad, consultant in cardiology and sounds waves to capture moving images. promoted to reader in respiratory medicine cardiovascular magnetic resonance, is now professor of Professor Alain Fraisse, consultant paediatric cardiologist at the • Professor Anand Devaraj, consultant thoracic radiologist, is cardiomyopathy Trust, carried out the first of this type of catheter intervention in now professor of practice in thoracic radiology • Professor Stuart Rosen, consultant cardiologist, becomes October 2016 and he said: “This procedure offers young paediatric professor of practice in cardiology. patients and their families hope through a less invasive treatment Professor Alain Fraisse and members of the paediatric team than surgery, with a shorter hospital stay and no chest scar.” Royal Brompton Clinical Trials team scores Respiratory leadership role of our specialist clinician hat trick at Clinical Research Awards Dr Peter George, consultant respiratory physician at RB&HH Specialist Care, has been appointed as The Royal Brompton Cystic and the public. In addition, Professor the new Respiratory Specialty Lead for the National Fibrosis (CF) Clinical Trials team Jane Davies, honorary consultant in paediatric respiratory medicine at Royal Institute for Health Research North West London celebrated three well-deserved Brompton & Harefield NHS Foundation Clinical Research Network (NIHR CRN). wins at the North West London Trust, received the award for outstanding Clinical Research awards, principal investigator, and Rebecca The aim of the NIHR CRN is to support clinical research presented by the National Dobra, Clinical Research Fellow, received infrastructure and work towards increased access for patients to Institute for Health Research’s the ‘Rising Star’ award. new and better treatments. Clinical Research Network, where Professor Davies said: “We are delighted Dr George said: “It’s a real honour to be appointed to this NIHR they were recognised for their to have been recognised in this endeavour. leadership role. I am excited to be joining a team which is committed to embedding a culture of research for the benefit of outstanding work carrying out I’d like to take this opportunity to thank patients in North West London and throughout the UK.” ground-breaking CF research. the Cystic Fibrosis Trust for their funding, our collaborators for all their hard work, The team accepted the award for but most of all the people with CF and outstanding collaborative work, their families, who have worked so hard recognising the teams work delivering with us to bring new drugs through trials Professor Jane Davies receiving the award for outstanding principal investigator. better clinical research to patients to clinical reality.” Dr Peter George Consultant respiratory physician, clinical lead for interstitial lung disease Royal Brompton & Harefield Hospitals Specialist Care Case Notes International Edition 2020 Royal Brompton & Harefield Hospitals Specialist Care Case Notes International Edition 2020 4 5 World-class care across three London locations At RB&HH Specialist Care, you 77 Wimpole Street outpatient can access private care at three Royal Brompton Hospital Harefield Hospital and diagnostic facility convenient locations across London: Royal Brompton Hospital, Harefield Royal Brompton Hospital is a specialist heart and lung centre Harefield Hospital is a specialist heart and lung hospital in the Based in the famous Harley Street Medical Area., our dedicated in the heart of London’s world-renowned Royal Borough of beautiful leafy surroundings of west London. It has luxurious outpatient and diagnostic facility brings our world-leading Hospital and 77 Wimpole Street. Kensington and Chelsea. inpatient and outpatient facilities for private patients, to ensure consultants from both hospitals to one convenient location close maximum comfort during their stay. to the shops of Oxford Street. It has dedicated inpatient and outpatient facilities for private patients, with access to some of the most advanced diagnostic It was the location of the UK’s first heart and lung transplant, Services include: equipment and medical devices in the world. In addition, with by the internationally-renowned surgeon, Professor Sir Magdi • Consultations for cardiology, cardiac surgery, respiratory its close proximity to the shops of Knightsbridge and some Yacoub, and continues to be a world-leading centre of excellence medicine, thoracic surgery, paediatric care, general medicine of London’s most famous museums on Exhibition Road, it is for heart and lung care. It has five operating theatres, four and health screening. ideally located for international patients and their families who catheter laboratories, a dedicated high-dependency unit and more wish to explore London during their stay. than 1,300 staff. • Diagnostics including: - echocardiography It has five operating theatres, one hybrid theatre, four catheter Services: laboratories and over 2,200 staff. For patients with greater - electrocardiogram (ECG) • Full range of imaging services including MRI for both cardiac care needs, a state-of-the-art high-dependency unit (HDU) is - magnetic resonance imaging (MRI) and general assessment; CT across cardiac, lung and general; located on-site. echocardiography (transthoracic, stress and contrast-enhanced) - cardiac magnetic resonance imaging (CMR) Services: and non-invasive cardiology including cardiac monitoring - positron emission tomography – computer tomography (PET-CT) exercise tolerance tests and ECG • Full range of imaging services including ultrasound, nuclear - computerised tomography (CT) – cardiac and general medicine, CT scans, cardiac magnetic resonance (CMR) and • Juniper ward, Harefield Hospital’s dedicated private patients - lung function ward with 16 single-occupancy rooms (all with ensuite fluoroscopy - chest x-ray. bathrooms)
Recommended publications
  • Confirmed Minutes of the London Regional Transfusion
    The London Regional Transfusion Committee Confirmed Minutes of the London Regional Transfusion Committee London Blood Transfusion Forum (RTC Business Meeting) held on 14 October 2016 at The Atrium, Royal Free Hospital Present: Abdul Adamu (AA) Whttington Hospital Anita Aggrey (AAG) Barnet General Hospital Shubha Allard (SA) Barts Health/NHSBT Magda Al-Obaidi (MAO) West Middlesex University Hospital Mariam Ammoun (MA) Hammersmith Hospital Namal Bandara (NB) Kings College Hospital Lorraine Barwick (LB) Great Ormond Street Hospital Chetan Bhatt (CB) Whittington Hospital Dilraj Birdee (DB) Hammersmith Hospital Heather Brotherton (HB) Chase Farm Hospital Alison Brownell (AB) Queens Hospital Romford Elaine Carter-Leay (ECL) Queens Hospital Romford Sandeepa Chandarana (SC) Barnet General Hospital Vashira Chiroma (VC) Hammersmith Hospital Gavin Cho (GC) NHSBT Sarah Clark (SC) Royal Free Hospital Michelle Conway (MC) Harefield Hospital Bernadette Cruz (BC) Northwick Park Hospital Helena Day (HD) Harefield Hospital Ciara Donohue (CD) Royal Free Hospital Oluwatola Elegbe (OE) Barts Health Fernando Fegarido (FF) Kings College Hospital Matthew Free (MF) SWL Pathology - St. George’s Hospital Diana Gabriel (DG) Barts Health Champika Gamlath (CG) Kings College Hospital Lisa Gibb (LG) Great Ormond Street Hospital Jan Gordon (JG) Chelsea & Westminster Hospital Christy Green (CG) Royal London Hospital Jane Harris (JH) New Victoria Hospital Amanda Hobson (AH) Royal Free Hospital Dena Howlett (DH) Epsom General Hospital Charmaine Jardiel (CJ) West Middlesex
    [Show full text]
  • RBH-CHD Network Annual Report.Pdf
    The Royal Brompton & Harefield Hospital NHS Foundation Trust Royal Brompton Hospital Congenital Heart Disease Network 2018/19 Annual Report Authors: Dr Nitha Naqvi Dr Leonie Wong Lawrence Mack Simon Boote Approved by: Congenital Heart Disease Working Group Ratification Committee: Congenital Heart Disease Network Board Date Ratified: 29/04/2019 Chairman: Dr Angela Tillett Implemented by: For reference only Issue Date: April 2019 Version: 001 Review Date: March 2020 Review interval: 12 Months Issued: April 2019 Version: 001 Page | 1 Link - Contents 1 Contents Page 1 Contents Page .......................................................................................................................................... 2 2 A message from our Clinical Director ................................................................................................... 4 3 RBH-CHD Network Strategic Vision Statement .................................................................................. 5 4 Summary of Achievements Against our Work Plan – 2018/19 ......................................................... 5 5 Research ................................................................................................................................................... 6 5.1 Grants Awarded ................................................................................................................................ 7 5.2 Research Programmes Peer Reviewed Publications ................................................................. 7 5.3 Research Strategy
    [Show full text]
  • Royal Brompton Hospital Nhs Trust
    ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST LOCUM CONSULTANT IN CYSTIC FIBROSIS Applications are invited for the post of Locum Consultant in Cystic Fibrosis six month fixed term contract. The Royal Brompton & Harefield NHS Foundation Trust is seeking to appoint a LOCUM CONSULTANT IN CYSTIC FIBROSIS to be based at the Royal Brompton Hospital. The Trust is a world famous organisation with a proud history in the investigation, treatment and research of lung and heart disease. We are particularly proud of our ability to provide comprehensive specialist care for patients of all ages and their families. The post will be based at The Royal Brompton Hospital and the successful candidate will work closely with the current physicians in the Cystic Fibrosis Unit to lead the cystic fibrosis service, which attracts tertiary referrals from all over the UK. Applicants are required to be fully registered Medical Practitioners and must be on the GMC’s Specialist Register or be eligible for admission to the Register within three months from date of interview for the post. Informal enquiries may be made to Dr Nicholas Simmonds, Consultant in Respiratory Medicine on 0207 351 8997. For an application form and job description, please contact our Medical Recruitment Manager by email on [email protected] or 0207 351 8688 quoting reference number 312-LC-CF-0915 and we will organise for an application pack to be sent out to you. Alternatively, applications can be made via the NHS jobs website www.jobs.nhs.uk We regret that we are unable to contact applicants who are not selected for an interview, therefore if you do not hear from us within three weeks after the closing date, please assume you have not been successful on this occasion.
    [Show full text]
  • Studies of ACE-Inhibition and Nitrate Supplementation
    Augmenting Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease: Studies of ACE-inhibition and Nitrate Supplementation Katrina Jane Curtis The Muscle Laboratory, Royal Brompton Hospital National Heart & Lung Institute, Imperial College London Submitted for the degree of Doctor of Philosophy (PhD) Imperial College London 1 Declaration of originality The data present in this thesis are the result of my original work. Where appropriate the contribution made by other persons has been appropriately acknowledged. Statement of contribution Contributions were made by Kawah Li and Professor Hugh Montgomery at University College London, who performed the ACE genotyping. In addition, Magda Minnion and Professor Martin Feelisch at the University of Southampton performed the measurement of the plasma nitrate and nitrite levels. Juliet Polkey provided assistance with the isotime data analysis in the nitrate supplementation work. Victoria Meyrick and Bhavin Mehta led the pulmonary rehabilitation programme at the Royal Brompton Hospital, and the team at Harefield Hospital are also acknowledged for their assistance in this respect. Copyright declaration The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives license. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the license terms of this work. Sources of funding The research in the thesis was funded by the Medical Research Council (grant reference MR/J000620/1) and the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, where it was undertaken.
    [Show full text]
  • FORMATO PDF Ranking Instituciones No Acadã©Micas Por Sub áRea
    Ranking Instituciones No Académicas por sub área OCDE 2020 6. Humanidades > 6.03 Filosofía, Ética y Religión PAÍS INSTITUCIÓN RANKING PUNTAJE FRANCE Centre National de la Recherche Scientifique (CNRS) 1 5,000 RUSSIA Russian Academy of Sciences 2 5,000 USA National Institutes of Health (NIH) - USA 3 5,000 RUSSIA Institute of Philosophy, Russian Academy of Sciences 4 5,000 SPAIN Consejo Superior de Investigaciones Cientificas (CSIC) 5 5,000 USA Seattle Children's Hospital 6 5,000 USA NIH Clinical Center (CC) 7 5,000 USA VA Boston Healthcare System 8 5,000 SLOVAKIA Slovak Academy of Sciences 9 5,000 ARGENTINA Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) 10 5,000 SPAIN CSIC - Instituto de Lenguas y Culturas del Mediterraneo y Oriente Proximo (ILC) 11 5,000 NETHERLANDS Erasmus University Medical Center 12 5,000 NETHERLANDS Academic Medical Center Amsterdam 13 5,000 USA Harvard School of Dental Medicine 14 5,000 GERMANY Helmholtz Association 15 5,000 USA University of Illinois Chicago Hospital 16 5,000 USA Mayo Clinic 17 5,000 FRANCE CNRS - Institute for Humanities & Social Sciences (INSHS) 18 5,000 GERMANY Max Planck Society 19 5,000 AUSTRALIA Florey Institute of Neuroscience & Mental Health 20 5,000 USA The World Bank 21 5,000 CZECH REPUBLIC Czech Academy of Sciences 22 5,000 USA NIH National Institute of Environmental Health Sciences (NIEHS) 23 5,000 NETHERLANDS VU UNIVERSITY MEDICAL CENTER 24 5,000 FRANCE Institut National de la Sante et de la Recherche Medicale (Inserm) 25 5,000 NETHERLANDS Utrecht University Medical
    [Show full text]
  • What Do Imperial Medicine* Postgraduates Do?
    What do Imperial Medicine* postgraduates do? Graph 1 – Destinations of 2016 graduates Percentage Entered Employment 66% Entered Further Study/Training 30% Seeking Employment 2% Not Available for Employment/Study/Training 2% Graph 2 – Comparison with previous years 2014 2015 2016 Entered Employment 56% 71% 66% Entered Further Study/Training 32% 23% 30% Seeking Employment 5% 3% 2% Not Available for Employment/Study/Training 7% 3% 2% Graph 3 – Sector of employment entered 2014 2015 2016 Agriculture 0.0% 0.6% 0.0% Oil/Mining 0.0% 0.0% 0.0% Manufacture 2.5% 4.1% 3.8% Utilities & Transport 0.0% 0.0% 0.0% Technical Consultancy/R&D 5.8% 2.4% 3.2% IT & Telecommunications 1.7% 2.9% 0.6% Banking/Financial 1.7% 0.0% 1.3% Accountancy 1.7% 0.6% 0.6% Business & Management Consultancy 1.7% 1.8% 0.6% Other Business Activities 5.0% 4.1% 6.4% Public Administration/Defence 1.7% 5.3% 6.4% Education 38.3% 23.5% 23.7% Health/Social Work 36.7% 52.9% 50.0% Others 3.3% 1.8% 3.2% *This data incorporates the Departments of Medicine; the Institute of Clinical Science; Public Health; Surgery & Cancer; and the National Heart and Lung Institute Careers Service www.imperial.ac.uk/careers Postgraduate Taught Courses Examples of employers and occupations for Medicine et al taught postgraduates who entered employment Examples of Employers Examples of Occupations • Academy of Education Development • Academic Clinical Fellow in General Practise • Aintree Hospital • Account Executive • Assemblies of God church • Associate Project Manager • Associate • Associate Scientist •
    [Show full text]
  • VIVOTM Non-Invasive Time Assessment Protocol
    TM VIVO non-invasive Time Assessment Protocol Short Study Title/Acronym: VIVOTM mapping Protocol REC Reference: Insert REC Reference IRAS Reference: 257755 CHIEF INVESTIGATOR: Dr Sabine Ernst, Consultant Cardiologist and Reader in Cardiology, Lead for Electrophysiology Research for the Royal Brompton Hospital Royal Brompton Hospital (RBH) Sydney Street London SW3 6NP Phone: 00442073518612 Email: [email protected] Fax: 00442073518131 SPONSOR REPRESENTATIVE: Mr Patrik Pettersson Royal Brompton and Harefield NHS Foundation Trust (RB&HFT) Royal Brompton Hospital (RBH) Research Office Chelsea Wing, Level 2 Sydney Street London SW3 6NP Phone: 0207 352 8121 ext. 8736 Email: [email protected] Fax: 0207 351 8829 VIVOTM mapping protocol VIVO-RBH01 Revision A – 15th January 2019 Page 1 of 38 Information in this protocol is confidential and should not be disclosed, other than to those directly involved in the execution or the ethical review of the study, without written authorisation from RB&HFT Research Office. Signature Page The Chief Investigator (CI) and the Research Office have discussed and agreed this study protocol. The investigators agree to perform the investigations outlined in this study protocol and to abide by this protocol except in the case of medical emergency that will be notified to the Research Office. The Investigator agrees to conduct the study in compliance with the study protocol and/or any subsequent amendments approved by the Sponsor and HRA, the Data Protection Act (1998), the Trust Information Governance Policy (or other local equivalent as applicable), the Research Governance Framework for Health & Social Care, 2nd Edition (2005), the Sponsor’s SOPs, and any other applicable regulatory requirements.
    [Show full text]
  • The Royal Brompton & Harefield Hospital NHS Foundation Trust
    The Royal Brompton & Harefield Hospital NHS Foundation Trust Royal Brompton Hospital Congenital Heart Disease Network 2019 / 20 Annual Business Plan Authors: Dr Nitha Naqvi Dr Leonie Wong Lawrence Mack Simon Boote Approved by: Congenital Heart Disease Working Group Ratification Committee: Congenital Heart Disease Network Board Date Ratified: 29/04/2019 Chairman: Dr Angela Tillett Implemented by: All Document Authors Meeting Chair Meeting Members Network Management Team Issue Date: April 2019 Version: 001 Review Date: March 2020 Review interval: 12 Months Issued: April 2019 Version: 001 Page | 1 Contents Page Link 1 Contents 1 Contents ................................................................................................................................................................... 2 2 The Brompton Hospital and Congenital Heart Disease ................................................................................... 3 3 The Annual Business Plan .................................................................................................................................... 3 4 Governance & Committee Structure ................................................................................................................... 3 5 RBH-CHD Strategic Vision ................................................................................................................................... 4 6 Operational Delivery Network ..............................................................................................................................
    [Show full text]
  • Efficacy and Safety of TOBI Podhaler in Pseudomonas Aeruginosa-Infected Bronchiectasis Patients: Ibest Study
    ORIGINAL ARTICLE BRONCHIECTASIS Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study Michael R. Loebinger1,2, Eva Polverino3, James D. Chalmers4, Harm A.W.M. Tiddens5,6, Herman Goossens7, Michael Tunney8, Felix C. Ringshausen 9, Adam T. Hill10, Rashidkhan Pathan11, Gerhild Angyalosi12, Francesco Blasi 13,14, Stuart J. Elborn2,15,16 and Charles S. Haworth17,18 on behalf of the iBEST-1 Trial Team Affiliations: 1Host Defence Unit, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK. 2Imperial College London, London, UK. 3Respiratory Disease Department, Vall d’ Hebron University Hospital – VHIR, Barcelona, Spain. 4Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. 5Dept of Paediatric Pulmonology and Allergology, Erasmus Medical Centre Sophia Children’s Hospital, Rotterdam, The Netherlands. 6Dept of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands. 7Dept of Clinical Microbiology, University Hospital Antwerp, Antwerp, Belgium. 8Halo Research Group, School of Pharmacy, Queen’s University Belfast, Belfast, UK. 9Dept of Respiratory Medicine, Hannover Medical School, and Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany. 10Dept of Respiratory Medicine, Royal Infirmary of Edinburgh, and University of Edinburgh, Edinburgh, UK. 11Novartis Healthcare Private Limited, Hyderabad, India. 12Novartis Pharma AG, Basel, Switzerland. 13Internal Medicine Dept, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. 14Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy. 15Halo Research Group, Centre for Experimental Medicine, Queen’s University Belfast, Belfast, UK. 16Imperial College and Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK.
    [Show full text]
  • Joint Appointment of Consultant Neurologist
    Joint Appointment of Consultant Neurologist Emergency Care and Integrated Care Division, Chelsea and Westminster Hospital – 8PA Regional Neurosciences Unit, Imperial College Hospitals, Charing Cross Hospital – 2PA JOB DESCRIPTION About our organisation Chelsea and Westminster Hospital NHS Foundation Trust provide services from two main hospitals, Chelsea and Westminster Hospital and West Middlesex University Hospital, and a number of clinics across London and the South-East. We have nearly 6,000 members of staff that care for nearly one million people locally, regionally, nationally and internationally. Both hospitals provide full clinical services, including full maternity, emergency and children’s, in addition to a range of community-based services across London, such as award-winning sexual health and HIV clinics. We are one of the best performing FTs in London for A&E waiting times, and mortality rates are better than average. Since the Care Quality Commission last inspected our hospitals we have taken on responsibility for a range of new services. Our new services include: Cardiac catheter service and a paediatric assessment unit on the West Middlesex site Surgical assessment unit on the Chelsea site New sexual health clinic at 10 Hammersmith Broadway Virtual fracture clinics Learning disabilities passports Plans are in place for a £20 million expansion to critical care facilities and refurbishment of the children’s unit at West Middlesex, both in partnership with the Trust’s dedicated charity CW+. Our priorities 1. Deliver high-quality patient-centred care Patients, their friends, family and carers will be treated with unfailing kindness and respect by every member of staff in every department and their experience and quality of care will be second to none.
    [Show full text]
  • Patient Booklet 03/09/2014 16:41 Page 2
    Info for patients - RBH.qxp:Patient Booklet 03/09/2014 16:41 Page 2 A lifetime of specialist care Royal Brompton Hospital Information for inpatients Info for patients - RBH.qxp:Patient Booklet 03/09/2014 16:41 Page 3 Table of contents Before you come into hospital 3 Coming into hospital 5 Arriving at hospital 7 Hospital staff 8 On and around the ward 11 Visitors 13 Your rights while in hospital 16 Going home 19 Feedback 20 Royal Brompton & Harefield Hospitals Charity 22 Hospital volunteers 23 This leaflet gives you general information about your stay at Royal Brompton Hospital. Our hospital is a national and international centre for the treatment of, and research into, heart and lung disease. Please ask us if you have any questions. 2 Info for patients - RBH.qxp:Patient Booklet 03/09/2014 16:41 Page 4 Information for inpatients Before you come into hospital Please read this booklet before What to bring with you you come into hospital. You will also have received your Registration form registration form and Please bring your completed admission letter. Please read registration form with you, them carefully. along with your admission letter. Bed availability Royal Brompton & Harefield Medicines and prescription NHS Foundation Trust is a It is important that you bring specialist centre for heart and your current prescription and lung disease and we accept all the medicines you are patients from all over the taking with you to hospital in United Kingdom. Sometimes, their original containers. These emergency patients have to should include any medicines take priority and we have to you may have bought over the cancel or delay planned counter without a admissions.
    [Show full text]
  • Appendix G Royal Brompton Harefield NHS Foundation Trust Private
    private patients’ centre Royal Brompton and Harefield Hospitals London Royal Brompton & Harefield Brompton Royal 04 our mission 06 our reputation 11 patient services 18 personalised service and specialised care 24 location and contact information 25 pricing policy 2 private patients centre patients private Welcome to Royal Brompton and Harefield Hospitals Private Patients’ Centre A warm welcome to Royal Brompton and Harefield Hospitals Private Patients’ Centre. This brochure provides valuable information on the important, life-changing work we do for people with heart and lung conditions. It will help you form a picture of the services we provide, the people who deliver the clinical expertise and care that contributes to our world-class reputation, and the environment in which our complex clinical and research work takes place. The hospitals are the largest specialist heart and lung centre in the UK and among the largest in Europe. We welcome patients and attract staff from all over the world. So from the moment you first come into contact with us, until the time you leave, you will become part of a community of people who have benefited from over 160 years of expert diagnosis, treatment and care of cardiac and thoracic conditions. We look forward to welcoming you here in London in the very near future. 3 Royal Brompton & Harefield & Brompton Royal our mission International leadership for the benefit of all Our vision is to maintain and strengthen our They provide specialist care and create and reputation as the leading national and disseminate clinical knowledge that will international centre for the diagnosis, benefit people today and the generations treatment and care of people with heart and to come.
    [Show full text]